<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Thirty patients with cerebral <z:e sem="disease" ids="C0003708" disease_type="Disease or Syndrome" abbrv="">arachnoiditis</z:e> and 26 with <z:e sem="disease" ids="C0027804" disease_type="Mental or Behavioral Dysfunction" abbrv="">neurasthenia</z:e> were found to have differences in the content of <z:chebi fb="19" ids="28790">serotonin</z:chebi>, 5-hydroxyindoleacetic++ acid and <z:chebi fb="9" ids="16796">melatonin</z:chebi> in the cerebrospinal fluid, which depended in <z:e sem="disease" ids="C0003708" disease_type="Disease or Syndrome" abbrv="">arachnoiditis</z:e> on the degree of intracranial pressure elevation </plain></SENT>
<SENT sid="1" pm="."><plain>The data on <z:chebi fb="19" ids="28790">serotonin</z:chebi> metabolism can be used in objective evaluation of the organic background in neurotic patients and serve for estimating the intensity of <z:hpo ids='HP_0000822'>hypertension</z:hpo> in patients with cerebral <z:e sem="disease" ids="C0003708" disease_type="Disease or Syndrome" abbrv="">arachnoiditis</z:e> </plain></SENT>
</text></document>